Mylène Bohec

7PUBLICATIONS
72CO-AUTHORS
Molecular targetsArchaeology of Australia (excl. Aboriginal and Torres Strait Islander)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 10, 2026
DNMT3B plays antagonistic roles with SMARCB1 and is a targetable vulnerability in rhabdoid tumors.

|Mar 17, 2026
Combining Population Genomics With Ancient DNA to Understand Island Colonisation History of the Madagascar Turtle Dove.

Nisha Dwivedi, Sean P Heighton, Romuald Laso-Jadart

|Apr 01, 2024
Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer.

Hugo Croizer, Rana Mhaidly, Yann Kieffer

|Feb 12, 2024
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway.

Monika Licaj, Rana Mhaidly, Yann Kieffer

|Nov 29, 2023
KDM6B drives epigenetic reprogramming associated with lymphoid stromal cell early commitment and immune properties.

Marvin Sylvestre, Nicolas Barbier, Vonick Sibut

|Oct 20, 2023
Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups.

María-Jesús Lobón-Iglesias, Mamy Andrianteranagna, Zhi-Yan Han

Pageof 2

Frequent Collaborators

6 joint publications

Sylvain Baulande

3 joint publications

Fatima Mechta-Grigoriou

2 joint publications

Olivier Delattre

2 joint publications

Yann Kieffer